MedPath

Comparison on the prevention of household influenza infection between baloxavir marboxil and neuraminidase inhibitors using health insurance claims database -2018/2019 influenza season

Not Applicable
Conditions
Influenza virus infection
Registration Number
JPRN-UMIN000038155
Lead Sponsor
Shionogi & Co., Ltd.
Brief Summary

please refer described below: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciaa1622/5939856

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
208225
Inclusion Criteria

Not provided

Exclusion Criteria

1)Families in which no family member was identified other than the IC 2)Families which had two or more ICs 3)Families whose IC was hospitalized after outpatient diagnosis 4)Families whose IC received several anti-influenza drugs

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Occurrence of household influenza infection
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath